Kiran Mazumdar-Shaw

Founder And Executive Chairperson, Biocon

$3.28B

$3.2M (-0.1%)

as of 04/20/26

About Kiran Mazumdar-Shaw

Kiran Mazumdar-Shaw, one of India's richest self-made women, founded biopharmaceutical firm Biocon, in 1978. The firm has successfully forayed into the lucrative U.S. market, and it also has one of Asia's largest insulin factories in Malaysia's Johor region.

In December 2025, Biocon announced that it is buying the rest of privately held subsidiary Biocon Biologics to consolidate its biosimilars and generics drug businesses. The deal values Biocon Biologics at $5.5 billion, it said.

Biocon Biologics acquired the biosimilars business of U.S. drugmaker Viatris in 2022 for $3.3 billion.

In 2022, the Central Bureau of Investigation arrested a Biocon Biologics executive and four others in an alleged bribery case. The company denied any wrongdoing.

Biocon-backed cancer therapy company Bicara Therapeutics raised $362 million in an IPO on the Nasdaq in September 2024.

Personal stats

Citizenship

India

Source of wealth

Biopharmaceuticals

Residence

Bangalore, India

Marital status

Widowed

Birth date

03/23/53 (age 73)

Education

Bachelor of Arts/Science, Bangalore University; Master of Science, Melbourne University

Self-made

self-made